Congenital Fiber Type Disproportion

Overview of Congenital Fiber Type Disproportion

Most recent studies have shown that Congenital Fiber Type Disproportion shares some biological mechanisms with atrophy, central-core-myopathy-(disorder), congenital-abnormality, congenital-myopathy-(disorder), congenital-structural-myopathy, dystrophy, hypertrophy, muscle-hypotonia, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathies-nemaline, myopathy, myotonic-dystrophy, neuromuscular-diseases, ophthalmoplegia, respiratory-failure, scoliosis-unspecified, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Congenital Fiber Type Disproportion, and have been seen in publications frequently: Autolysis, Cellular Localization, Innervation, Localization, Muscle Atrophy, Muscle Contraction, Pathogenesis, Reflex, Regeneration, Regulation Of Muscle Contraction

Quite a number of genes have been found to play important roles in Congenital Fiber Type Disproportion, such as ACTA1, AMPD1, ANKRD1, DES, DMPK, GALC, GAP43, MTM1, MYH14, NEB, RYR1, THBD, TNNT1, TNNT3, TPM2, TPM3, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Congenital Fiber Type Disproportion Related Genes

click to see detail information for each gene

Pathways Related to Congenital Fiber Type Disproportion

This information is being compiled and will come in a future update

Related Diseases